Three epitopic peptides of the simian immunodeficiency virus Nef protein recognized by macaque cytolytic T lymphocytes
- PMID: 1370557
- PMCID: PMC240774
- DOI: 10.1128/JVI.66.2.750-756.1992
Three epitopic peptides of the simian immunodeficiency virus Nef protein recognized by macaque cytolytic T lymphocytes
Abstract
In 8 of 12 experimentally infected macaques, the Nef SIVmac 251 protein was recognized by cytolytic T lymphocytes (CTL) and appeared strongly immunogenic. Here, we report experiments which have been performed by using synthetic peptides to precisely determine the epitopes recognized by macaque CTL. Three epitopes of the Nef protein have been defined as CTL targets in three macaques. The epitopic peptides are located in the central region of the protein, and all of them show high homology with peptides of the human immunodeficiency virus type 1 Nef protein recognized by human CTL in association with several human leukocyte antigen molecules. These results suggest that (i) the Nef protein is a good candidate for vaccination not only because of its early expression but also because of its high immunogenicity for CTL, (ii) long peptides covering the central region of this protein could be used as vaccines and could cross the major histocompatibility complex barrier in a large variety of individuals, and (iii) the rhesus macaque is a good animal model in which to test for protection by CTL.
Similar articles
-
DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses.Virology. 2001 Jan 5;279(1):136-45. doi: 10.1006/viro.2000.0705. Virology. 2001. PMID: 11145897
-
Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.Virology. 2000 Dec 20;278(2):551-61. doi: 10.1006/viro.2000.0671. Virology. 2000. PMID: 11118377
-
Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?J Virol. 2002 Nov;76(22):11623-36. doi: 10.1128/jvi.76.22.11623-11636.2002. J Virol. 2002. PMID: 12388723 Free PMC article.
-
Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction.Semin Immunol. 1993 Jun;5(3):215-23. doi: 10.1006/smim.1993.1025. Semin Immunol. 1993. PMID: 8394161 Review.
-
Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection.Immunol Rev. 2001 Oct;183:115-26. doi: 10.1034/j.1600-065x.2001.1830110.x. Immunol Rev. 2001. PMID: 11782252 Review.
Cited by
-
Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5).J Virol. 1995 Oct;69(10):6289-96. doi: 10.1128/JVI.69.10.6289-6296.1995. J Virol. 1995. PMID: 7666529 Free PMC article.
-
Cellular and humoral antigenic epitopes in HIV and SIV.Immunology. 1992 Aug;76(4):515-34. Immunology. 1992. PMID: 1383131 Free PMC article. Review. No abstract available.
-
An epitope in the V1 domain of the simian immunodeficiency virus (SIV) gp120 protein is recognized by CD8+ cytotoxic T lymphocytes from an SIV-infected rhesus macaque.J Virol. 1994 Apr;68(4):2756-9. doi: 10.1128/JVI.68.4.2756-2759.1994. J Virol. 1994. PMID: 7511178 Free PMC article.
-
Rapid screening for Mamu-A1-positive rhesus macaques using a SIVmac Gag peptide-specific cytotoxic T-lymphocyte assay.Immunology. 1995 Mar;84(3):482-7. Immunology. 1995. PMID: 7751033 Free PMC article.
-
Adaptation of an R5 Simian-Human Immunodeficiency Virus Encoding an HIV Clade A Envelope with or without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants.J Virol. 2019 Apr 17;93(9):e02267-18. doi: 10.1128/JVI.02267-18. Print 2019 May 1. J Virol. 2019. PMID: 30760566 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources